Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, in Patients with Asthma or COPD, Evaluated Using Functional Respiratory Imaging.
Saved in:
| Title: | Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, in Patients with Asthma or COPD, Evaluated Using Functional Respiratory Imaging. |
|---|---|
| Authors: | Tousi NM; FLUIDDA NV, Kontich, Belgium., Osello R; Global Technical Development, Chiesi Farmaceutici SpA, Parma, Italy., Santoro D; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., Campochiaro L; Global Technical Development, Chiesi Farmaceutici SpA, Parma, Italy., Bates JHT; University of Vermont, Burlington, Vermont, USA., Galkin D; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy., De Backer J; FLUIDDA Inc., New York, New York, USA., Sadafi H; FLUIDDA NV, Kontich, Belgium., Skloot G; Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy. |
| Source: | Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2026 Jun; Vol. 39 (3), pp. 133-140. Date of Electronic Publication: 2025 Nov 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-2703 (Electronic) Linking ISSN: 19412711 NLM ISO Abbreviation: J Aerosol Med Pulm Drug Deliv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1941-2703 |
|---|---|
| DOI: | 10.1177/19412711251396759 |
